A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
Status:
Withdrawn
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the dose of EZN-2232 that can be given to
MBL deficient pediatric cancer patients undergoing chemotherapy. The pharmacokinetics,
pharmacodynamics, and safety of the study drug will also be studied.